Catalyst Wire Dossier Catalyst Wire Dossier

Compound Sodium Alginate Double Action Chewable Tablets

sodium alginate · Reckitt Benckiser Healthcare (UK) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Compound Sodium Alginate Double Action Chewable Tablets, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients [Phase 3]

See pricing